Eptifibatide and wound secretion Patient Reports February 12, 2012

Eptifibatide Side Effects Report #5574374-2
Eptifibatide side effect was reported by a Physician from UNITED STATES on Dec 13, 2007. Female patient, 67 years of age, weighting 119.1 lb, was diagnosed with percutaneous coronary intervention and was treated with Eptifibatide. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, post procedural complication, wound secretion. Eptifibatide dosage: 3.5 ML; QH; IV. During the same period patient was treated with CLOPIDOGREL, HEPARIN. Patient was hospitalized. Patient recovered.

Eptifibatide Side Effects Report #5587744-3
Eptifibatide side effect was reported by a Physician from UNITED STATES on Jan 02, 2008. Female patient, 67 years of age, weighting 119.1 lb, was diagnosed with percutaneous coronary intervention and was treated with Eptifibatide. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, wound secretion. Eptifibatide dosage: unknown. During the same period patient was treated with CLOPIDOGREL, HEPARIN, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Eptifibatide Side Effects Report #4653360-0
Eptifibatide side effect was reported by a Physician from on May 04, 2005. Female patient, 50 years of age, weighting 175.3 lb, was treated with Eptifibatide. After drug was administered, patient experienced the following side effects: cardiac enzymes increased, nausea , puncture site reaction, wound secretion. Eptifibatide dosage: 2 (7.3 ML BOLUSES) / 13 ML/HR IV. During the same period patient was treated with FENTANYL, MORPHINE, MIDAZOLAM, NITROGLYCERIN, CLOPIDOGREL BISULPHATE, ASPIRIN, ZETIA, LEXAPRO. Patient was hospitalized. Patient recovered.